Manufacturer's investigation conclusion: a direct correlation between the patient outcome and heartmate 3 left ventricular assist system (lvas) (b)(4) cannot be conclusively determined through this evaluation.The patient was implanted with heartmate 3 lvas (b)(4) on (b)(6) 2021.On (b)(6) 2022 the patient expired due to unspecified reasons.The patient outcome was not considered to be device-related, and no device-related issues were reported in association with the patient outcome.Heartmate 3 left ventricular assist system (b)(4) will not be returned for evaluation as no autopsy was performed and it was not explanted for evaluation.Per hospital policy, no further information regarding the event will be provided at this time.The relevant sections of the device history records were reviewed and showed no deviation from manufacturing or quality assurance specifications.The heartmate 3 lvas instructions for use (ifu), rev.G, lists death as an adverse event that may be associated with the use of the heartmate 3 left ventricular assist system.No further information was provided.The manufacturer is closing the file on this event.
|